Mr. Ghanshyam Teli | Medicinal Chemistry | Best Researcher Award
School of Pharmacy, Sangam University, India
👨🎓Profiles
👨🎓 Early Academic Pursuits
Mr. Ghanshyam Teli’s academic journey began with a strong foundation in pharmacy. He earned his B. Pharmacy from Geetanjali University in 2019 with a commendable 73.7%. His academic pursuit continued with a M. Pharmacy from ISF College of Pharmacy in 2021, where he achieved an impressive 82%. Currently, he is pursuing his Ph.D. at Baba Farid University of Health Sciences, enhancing his expertise in the field. His early academic focus was on chemical synthesis and drug discovery, where he worked on several research projects related to anti-cancer agents and inhibitors of oncogenic pathways.
🧑🔬 Professional Endeavors
Mr. Teli has gained considerable professional experience, particularly in both academic and industrial settings. He has worked for 1.5 years as an Assistant Professor at the School of Pharmacy, Sangam University, Bhilwara, India, where he has been able to share his knowledge with students while continuing his research. His professional experience also includes 13 months at United Biotech Pvt Ltd as an Assistant R&D Chemist, where he contributed to several high-impact projects, including the synthesis of 4-Thiazolidinone derivatives and the development of Paclitaxel-HSA complex. Additionally, he spent 1 year as a Junior Research Fellow (JRF) at Acharya and B.M. Reddy College of Pharmacy in Bengaluru, further strengthening his research expertise.
🔬 Contributions and Research Focus
Mr. Teli's research contributions have primarily focused on drug design, synthesis, and evaluation, with a particular emphasis on creating compounds for anti-cancer treatment. His work on 4-thiazolidinone conjugates as potential anti-breast cancer agents is notable, along with his project on the discovery of triangular heterocyclic molecules to inhibit dual oncogenic pathways. His research aims to contribute to developing novel therapeutic strategies for cancer treatment, especially targeting HSP90 and BRAF kinases.
🌍 Impact and Influence
Mr. Teli's professional journey demonstrates his commitment to both academia and industry. His industrial experience has allowed him to engage in multi-step synthesis processes and biological evaluations, making a tangible impact on pharmaceutical development. As an educator, he strives to impart his knowledge and inspire the next generation of pharmacists, sharing insights from both his research and industry experience. His contributions aim to foster innovations in drug design and therapy, particularly in cancer treatments.
📚 Academic Cites and Recognition
While Mr. Teli’s academic work is still evolving, his research projects on drug discovery, particularly in the field of cancer, have the potential for future recognition and citations. His detailed work in the design and synthesis of bioactive compounds, particularly those related to anti-cancer and anti-breast cancer agents, is likely to gain traction and be cited by peers in the academic and research communities.
💻 Technical Skills
Mr. Teli is proficient in several technical aspects of pharmaceutical chemistry, including: Synthesis of chemical compounds and characterization through advanced spectroscopy techniques such as UV, IR, and 1H NMR. Docking studies and predicting ADMET properties (Absorption, Distribution, Metabolism, Excretion, and Toxicity) for potential drug candidates. Handling specialized equipment such as Flash Chromatography, Column Chromatography, Rota-evaporator, Vacuum dryer, UV-Vis Spectrophotometer, and pH meter. Expertise in computational tools like ChemDraw, Autodock, Molegro Virtual Docker (MVD), Pymol, and Discovery Studio, which aid in the structure-activity relationship (SAR) analysis and molecular modeling.
👩🏫 Teaching Experience
As an Assistant Professor at the School of Pharmacy, Sangam University, Mr. Teli has honed his teaching skills, fostering a rich learning environment. His ability to explain complex concepts in pharmacy and drug design to students reflects his deep knowledge and communication skills. His teaching approach emphasizes practical application and encourages critical thinking. By sharing his industrial and research experiences, he connects students with real-world pharmaceutical challenges, aiming to inspire future innovations.
🌱 Legacy and Future Contributions
Mr. Teli’s ongoing research and academic efforts hold significant promise for the future of pharmacy education and drug discovery. His work on the synthesis of novel anti-cancer agents, especially those targeting key oncogenic pathways, has the potential to drive breakthroughs in cancer therapy. As he continues to pursue his Ph.D., Mr. Teli is committed to growing as a researcher and educator. He seeks to expand his knowledge, hone his technical skills, and make valuable contributions to drug development while guiding the next generation of pharmaceutical professionals.
📖Notable Publications
-
Synthetic product-based approach toward potential antileishmanial drug development
- Authors: Pal, R., Teli, G., Akhtar, M.J., Matada, G.S.P.
Journal: European Journal of Medicinal Chemistry
Year: 2024 -
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
- Authors: Pal, R., Teli, G., Sengupta, S., Maji, L., Purawarga Matada, G.S.
Journal: Journal of Biomolecular Structure and Dynamics
Year: 2024 -
Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase
- Authors: Teli, G., Pal, R., Maji, L., Purawarga Matada, G.S., Sengupta, S.
Journal: Journal of Biomolecular Structure and Dynamics
Year: 2024 -
Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
- Authors: Pal, R., Teli, G., Matada, G.S.P., Dhiwar, P.S.
Journal: Journal of Molecular Structure
Year: 2023 -
The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis
- Authors: Pal, R., Teli, G., Akhtar, M.J., Matada, G.S.P.
Journal: European Journal of Medicinal Chemistry
Year: 2023